Explore Efficacy of FMT Treating Childhood ASD Patients

Exclusion Criteria

• •1. Patients diagnosed with severe malnutrition;
• •2. Patients depend on tube feeding (liquid food);
• •3. Patients with a serious gastrointestinal disease requiring immediate treatment (or life-threatening);
• •4. Patients with primary immunodeficiency disease during screening;
• •5. Patients with a single-gene disorder;
• •6. Patients with a history of severe allergies;
• •7. Patients with severe fever and/or serious infection within 7 days prior to enrollment;
• •8. Patients with renal insufficiency and liver dysfunction (or creatinine \> 2 mg/dl, direct bilirubin \> 2 mg/dl);
• •9. Subjects with congenital or acquired immunodeficiency or immunosuppression (e.g., neoplastic disease or organ transplant) who have received or are undergoing chemotherapy, or have been diagnosed with HIV;
• •10. Patients with inflammatory bowel disease, celiac disease, large intestine irritation or eosinophilia, esophagitis, eosinophilic gastroenteritis or similar diseases;
• •11. Subjects with severe sensory or motor disorders (e.g., blindness, deafness, seizures, cerebral palsy);
• •12. Patients who are participating in other clinical studies, or have received interventions in other interventional clinical studies within 4 weeks prior to enrollment.